NCT05616624 2026-02-04ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung CancersWashington University School of MedicinePhase 1/2 Active not recruiting31 enrolled